Dr. Karen Kelly describes her thought process on which molecular markers are those clearly indicated for  patients with advanced NSCLC, as well as whether smoking status factors into her approach.

[powerpress]

Dr. Lecia Sequist describes the state of the art and her view of current best practices on molecular testing for advanced non-small cell lung cancer.

[powerpress]

Dr. Geoffrey Oxnard describes the new finding of individuals with an inherited T790M mutation in the EGFR gene, the unclear significance of it, and a study being conducted to learn more about it.

[powerpress]

We were fortunate enough to have Dr. William Pao of Vanderbilt-Ingram Cancer Center in Nashville join us to discuss his pioneering My Cancer Genome project in his own words:

[powerpress]

Last night I had the good fortune to attend the fun young lung dinner. I had a lot of fun seeing old friends, and greatly enjoyed making a few new ones: